The Wnt gene family encodes secreted signaling molecules that play important roles in tumorgenesis and embryogenesis. The canonical Wnt signaling pathway regulates target gene expression via the stabilization and nuclear translocation of the cytoplasmic pool of b-catenin. The activation of integrin-linked kinase (ILK) is also known to regulate the stabilization and subsequent nuclear translocation of b-catenin in several epithelial cell models. We now report that molecular and pharmacological inhibition of ILK activity in mammalian cells directly modulates Wnt signaling by suppressing the stabilization and nuclear translocation of b-catenin, as well as b-catenin/Lefmediated transcription. Inhibition of ILK activity, but not phosphatidylinositol-3 kinase (PI3K) or MEK activities suppresses nuclear b-catenin stabilization in cells stably expressing Wnt3a as well as in cells exposed to either Wnt3a conditioned media or purified Wnt3a. Furthermore, ILK inhibition reverses the Wnt3a-induced suppression of b-catenin phosphorylation that accompanies b-catenin stabilization. In addition, we show that ILK can be identified in a complex with Wnt pathway components such as adenomatous polyposis coli and GSK-3. Upon treatment of L cells with Wnt3a-CM, glycogen synthase kinase-3 (GSK-3b) becomes highly phosphorylated on Ser 9, which is completely abolished upon inhibition of ILK activity. However, acute exposure of L cells to purified Wnt3a does not result in the stimulation of GSK-3b Ser 9 phosphorylation, despite b-catenin stabilization. Together our data demonstrate that ILK activity can modulate acute Wnt3a mediated b-catenin phosphorylation, stabilization and nuclear activation in a PI3K-independent manner, as well as the more prolonged PI3K-dependent secondary effects of Wnt signaling on GSK-3 phosphorylation. Finally, we suggest that a novel small molecule inhibitor of ILK, QLT-0267, may be a useful tool in the regulation of pathological Wnt signaling.
Introduction
Wnt genes encode a large family of secreted glycoproteins that are involved in the control of gene transcription, cell adhesion and cell polarity (Miller et al., 1999; Giles et al., 2003) . Although Wnt signaling is considered a critical pathway in the development of both vertebrates and invertebrates (Cadigan and Nusse, 1997; Moon et al., 2002) , aberrant Wnt signaling has also been observed in some oncogenic processes (Cadigan and Nusse, 1997; Smalley and Dale, 1999; Waltzer and Bienz, 1999) . Wnt proteins exert many of their effects by activating the expression of target genes through the stabilization and nuclear accumulation of b-catenin Rubinfeld et al., 1997) , a protein originally identified as a component of the cadherin cell adhesion complex (Cowin, 1994) . In the absence of Wnt signaling, b-catenin is targeted for ubiquitin-mediated proteosomal degradation by paired phosphorylation by casein kinase I (CKI) and glycogen synthase kinase-3 (GSK-3b) (Polakis, 2002) . This phosphorylation is facilitated by a multiprotein complex composed primarily of GSK-3b, axin and adenomatous polyposis coli (APC) Morin et al., 1997; Brown and Moon, 1998; Hart et al., 1998; Seidensticker and Behrens, 2000; Bienz, 2002) . APC and axin are tumor suppressor proteins that are also phosphorylated by GSK-3b, which results in a more stable complex formed with b-catenin (Hart et al., 1998; Kishida et al., 1999) . In the presence of Wnt stimulation, these proteins are dephosphorylated, and therefore bind less efficiently to b-catenin Willert et al., 1999) resulting in accumulation of unphosphorylated bcatenin in the cytoplasm. b-catenin is ultimately translocated to the nucleus, where it mediates the expression of Wnt responsive genes via its interaction with the T-cell factor/lymphoid enhancing factor (Tcf/ Lef) family of transcription factors (Miller and Moon, 1996; Barth et al., 1997) .
Activation of the downstream components of the Wnt signaling pathway, namely inhibition of GSK-3 activity and nuclear accumulation of b-catenin, has also been achieved through overexpression of integrin-linked kinase (ILK) (Delcommenne et al., 1998; D'Amico et al., 2000; Persad et al., 2001b) . ILK is an ankyrinrepeat, containing serine/threonine protein kinase, that mediates integrin signaling via its interaction with the cytoplasmic domains of b1 and b3 integrins (Hannigan et al., 1996) . ILK also functions as an adapter protein, physically coupling downstream signals from both integrins and growth factors (Wu and Dedhar, 2001) . Extracellular matrices and growth factors each have been shown to stimulate phosphatidylinositol-3 kinase (PI3K)-dependent ILK signaling to downstream components in a number of diverse biological processes such as adhesion, cytoskeleton organization, migration, cell cycle progression, survival and angiogenesis (reviewed in Oloumi et al., 2004; Hannigan et al., 2005) . Inhibition of GSK-3b due to constitutively active and/or overexpressing ILK epithelial cells results in the translocation of b-catenin to the nucleus followed by an increase in bcatenin/Tcf transcriptional activity (Delcommenne et al., 1998; Novak et al., 1998; Persad et al., 2001b) . Alternatively, inhibition of ILK in APC mutant colon carcinoma cell lines results in a decrease in b-catenin stabilization, and a subsequent inhibition of b-catenin/ Lef-1 transcriptional activity , suggesting a cooperative role for APC in this process. ILK has also been shown to be present in focal adhesion complexes with dishevelled (Dvl), a cytoplasmic effector of Wnt signaling (Torres and Nelson, 2000) . Although these findings implicate ILK in the regulation of some of the components of the Wnt signaling pathway, the exact interaction between the two pathways remains unidentified.
In this study, we have investigated the role of ILK in Wnt3a-induced stabilization and activation of b-catenin-mediated transcription. We show that inhibition of ILK either pharmacologically or by transfection with a dominant-negative ILK (ILK-DN) results in a significant reduction in Wnt3a-stimulated Tcf/Lef transcriptional activity, as determined by a luciferase reporter assay. We also demonstrate that there is a dramatic reduction in the Wnt3a-induced nuclear accumulation of b-catenin, in both HEK293 and L cells, upon the inhibition of ILK activity. ILK inhibition also appears to reverse the Wnt3a-induced suppression of b-catenin phosphorylation. In addition, we discovered an increase in ILK kinase activity in Wnt3a-expressing L cells and demonstrate that ILK complexes with APC and GSK-3b, suggesting a direct role in regulation of b-catenin turnover. Our results also demonstrate an important role for ILK in the regulation of both acute, as well as the prolonged effects of Wnt3a signaling in mammalian cells in Wnt3a-induced stabilization of b-catenin and activation of Tcf/Lef transcription factor.
Results
Activation of the canonical Wnt signaling pathway Stable expression of several Wnt genes, including Wnt-1 and Wnt3a, stabilizes b-catenin in mammalian cells (Hinck et al., 1994; Papkoff et al., 1996; Shimizu et al., 1997) . In this study, in order to establish reproducible cell culture models in which the effect of the modulation of ILK could be investigated, we exposed HEK293 and L cells to conditioned media (CM) from Wnt3a-expressing L cells (Shibamoto et al., 1998) . HEK293 cells were exposed to 50% CM from Wnt3a expressing or parental L cells at different time points. Accumulation of b-catenin due to its stabilization was then assessed by Western blot analysis in both nuclear and cytoplasmic fractions. b-catenin was stabilized in both fractions as early as 1 h after stimulation with Wnt3a-CM and continued up to 24 h ( Figure 1a ). However, activation of Tcf/Lef transcription factors determined by TOPFlash luciferase reporter assay required overnight (16 h) stimulation (data with different time points not shown) with 10-50% Wnt3a-CM (Figure 1b) . Unstimulated L cells have been shown previously to have only trace amounts of b-catenin possibly due to the expression of low levels of cadherins (Nagafuchi and Takeichi, 1989) . However, high levels of b-catenin accumulate in these cells in response to Wnt3a-CM (Shibamoto et al., 1998; Willert et al., 2003) . We also demonstrate an intense b-catenin immunofluorescence, particularly in the nuclei of L cells, 2 h after stimulation with Wnt3a-CM ( Figure 1c ) consistent with the previous reports (Shibamoto et al., 1998) .
Inhibition of ILK activity decreases Wnt3a-induced activation of Tcf/Lef transcriptional activity We had previously reported an independent role for ILK in the activation of b-catenin/Lef-mediated gene transcription (Novak et al., 1998; Novak and Dedhar, 1999; Somasiri et al., 2001; Tan et al., 2001) . To determine whether Wnt-induced activation of the Tcf/ Lef transcription factor also requires ILK, we investigated the effect of inhibition of ILK activity on Wnt3a-induced activation of Tcf/Lef transcriptional activity in HEK293 cells. Modulation of ILK activity was achieved by transfection of a kinase-deficient, dominant negative, containing a point mutation in (E359K) in the kinase domain (Wu et al., 1998; Persad et al., 2001a) . Transient transfection of wild-type ILK (ILK-WT) increased Tcf/ Lef transcriptional activity over Wnt3a alone (Figure 2a ), whereas transfection of ILK-DN reduced the Wnt3a-induced activation of this transcription factor in a dose-dependent manner (Figure 2a) . ILK activity was also inhibited by treatment with a second generation of a highly selective small molecule ILK inhibitor, QLT-0267 (Zhou et al., 2004) , which inhibits ILK kinase activity in a dose-dependent manner (Troussard et al., 2006) . We have recently shown the specificity of this ILK inhibitor in another study by overexpressing a constitutively active mutant of ILK in the presence of QLT-0267, and showing that this active ILK rescued the effect of the inhibitor (Troussard et al.,
. QLT-0267 inhibits the kinase activity of ILK in a cell free assay at 26 nmol/l, and the analysis of 150 other protein kinases under similar conditions has shown the selectivity range of 10-to 1000-fold over other kinases (Younes et al., 2005; Troussard et al., 2006) . Preliminary experiments suggest B1000-fold selectivity over kinases such as CK2, CSK, DNA-PK, PIM1, protein kinase B or AKT kinase and PKC, and B100-fold selectivity over extracellular signal-regulated kinase 1, GSK3b, LCK, PKA, p70S6K and RSK1. Of those tested, the kinases that show the greatest inhibition by QLT-0267 include CDK1, CDK2 and CDK5, but the selectivity window is still at least 10-fold (QLT) (D Morrison, personal communication). The first widely used ILK inhibitor, KP-392, was identified in a high throughput kinase activity screen using active recombinant ILK (Persad et al., 2001a) , and was shown to specifically inhibit ILK kinase activity (D'Amico et al., 2000; Troussard et al., 2000; Persad et al., 2001a; Mills et al., 2003; Tan et al., 2004) . These ILK inhibitors do not affect cell viability at the concentrations used in this study as determined by Trypan blue staining (data not shown). The differences between the biochemical in vitro IC 50 and the effective concentrations required for cellbased activity most likely reflect variables such as cellular membrane permeability, subcellular compartmentalization and efficient drug efflux mechanisms. Such differences between the biochemical and cell-based activity are common to many small molecule inhibitors, constructs, and pRenilla, followed by an overnight stimulation with 50% of either Wnt3a-or C-CM. A dual luciferase assay was performed 48 h after transfection. The luciferase activities were normalized for pRenilla, the control reporter, activity.
The experiment was performed in three independent trials (data are mean7s.e. and represent three experiments; a ¼ 0.05). Thirty micrograms of each lysate from stimulated samples were run on SDS-PAGE and blotted for V5 epitope to demonstrate an increasing amount of the transfected ILK constructs. b-actin was used as a total protein loading control. *Indicates significant difference from Wnt3a-CM treated sample (no. 3 in the graph) (Po0.05). (b) Inhibition of ILK with QLT-0267 was done 3 h before overnight stimulation with Wnt3a-or C-CM. Luciferase activity was assayed as in (a). *Indicates significant difference from Wnt3a-CM treated sample (no. 5 in the graph) (Po0.05). (Shibamoto et al., 1998) .
including recently described CDK2/cyclin A inhibitors (Pevarello et al., 2004) . Inhibition of ILK with QLT-0267 in HEK293 cells transfected with either the luciferase reporter construct TOPFlash, or the control reporter construct FOPFlash, showed a specific inhibition of Wnt3a-induced activation of Tcf/Lef transcription factor (Figure 2b ). Wnt3a-induced TOPFlash activity is reduced to the same level as the control samples in the cells treated with the ILK inhibitor, reflecting the effectiveness of the inhibitor at lowering the ILK kinase activity by acting on the majority of the treated cells ( Figure 2b ). However, upon transient transfection with ILK-DN, the inhibition is only partially reduced, representing an average effect from both the transfected and non-transfected cells ( Figure 2a ). Together, these data demonstrate that ILK activity can modulate Wnt3a-induced activation of b-catenin-Tcf/Lef transcriptional activity.
Inhibition of ILK activity decreases Wnt3a-induced stabilization of b-catenin
We next examined the effect of the inhibition of ILK activity on Wnt3a-induced stabilization of b-catenin in both HEK293 and L cells. b-catenin stabilization is considered the key factor in the activation of the downstream components of Wnt signaling pathway (reviewed in Giles et al., 2003; Nelson and Nusse, 2004) . Wnt stimulation inhibits the ubiquitin-mediated degradation of b-catenin, resulting in its stabilization in both cytoplasmic and nuclear fraction, where it can then regulate gene expression by activating Tcf/Lef transcription factors. As seen in Figure 1a and b Wnt3a stimulation of both HEK293 and L cells results in accumulation of b-catenin both in the cytoplasmic and nuclear fraction of these cells. However, when the kinase activity of ILK was inhibited by treatment with QLT-0267, this Wnt3a-induced stabilization of b-catenin was reduced, with a more significant effect in nuclear accumulation in both cell lines as determined by Western blot analysis (Figure 3a and b). To ensure that the effects of QLT-0267 are ILK mediated, we transiently transfected ILK-DN into HEK293 cells, and this also resulted in a reduction in Wnt3a-induced stabilization of b-catenin in both the cytoplasmic and nuclear fraction in HEK293 cells (Figure 3c ). Immunofluorescence staining of L cells showed that treatment with Wnt3a-CM resulted in the accumulation of b-catenin in most of the nuclei of these cells. However, when the cells were treated with the above ILK inhibitor the intensity of nuclear b-catenin was dramatically reduced, as determined by indirect immunofluorescence (Figure 4a) . A subset of the cells showed a more significant reduction in nuclear b-catenin staining while still retaining the cytoplasmic staining of b-catenin (Figure 4b ). This is consistent with the Western blot data (Figure 3a and b) , and in agreement with observations that were made previously showing that while, ILK overexpresssion in scp2 mammary epithelial cells did not effect the steady-state level of b-catenin, it resulted in significant stimulation of nuclear localization of b-catenin (Somasiri et al., 2001) . Again to rule out off-target effects of QLT-0267, we transfected L cells with a myc-tagged ILK-DN construct and this also resulted in the downregulation of Wnt3a-induced accumulation of b-catenin as compared to the non-transfected cells based on the expression of the myc epitope tag, a representation of which is shown in Figure 4c . Depending on the level of myc expression (transfection efficiency), we either saw a complete loss of b-catenin, or b-catenin exclusion from the nucleus. Collectively, these data demonstrate a highly selective effect of ILK inhibition on the canonical Wnt signaling pathway.
Acute versus prolonged effect of Wnt3a on GSK-3b phosphorylation, and the role of ILK in this regulation In order to identify the mechanism for the role of ILK in Wnt-mediated stabilization of b-catenin, we compared the kinase activity of ILK in L cells stably expressing Wnt3a and the parental control. Although an equal amount of ILK protein is expressed in the samples assayed, the activity of ILK in Wnt3a expressing L cells was almost twice that of the ILK activity in the parental L cells (Figure 5a ).
The induction in ILK kinase activity in Wnt3a-expressing L cells prompted us to examine the effect of this induction on GSK-3 phosphorylation on Ser 9, which has been previously shown to be regulated by ILK (Delcommenne et al., 1998; Troussard et al., 1999; D'Amico et al., 2000; Zhou et al., 2004) . We observed a significant enhancement in GSK-3b phosphorylation on Ser 9 in L cells treated with Wnt3a-CM, as compared to the control media (Figure 5b) . The basal level of GSK-3 Role of ILK in Wnt3a-mediated b-catenin accumulation A Oloumi et al phosphorylation on Ser 9 was also significantly enhanced in serum-deprived Wnt3a-expressing L cells, compared to the parental cells (data not shown). This enhancement in GSK-3 phosphorylation on Ser 9 was dramatically reduced with the inhibition of ILK kinase activity by treatment with QLT-0267 (Figure 5b ). In order to determine whether the stimulation of phosphorylation of GSK-3b on Ser 9 in Wnt3a-CMtreated cells was direct or indirect, we exposed L cells to purified Wnt3a. Although purified Wnt3a induced a dramatic and acute stabilization of b-catenin, which was also completely blocked by the ILK inhibitor QLT-0267, the phosphorylation of GSK-3b on Ser 9 was unaffected (Figure 5c ). This suggests that the effect of Wnt3a-CM on GSK-3b Ser 9 phosphorylation was an indirect regulation from the stimulation of secondary signaling mechanism induced by Wnt3a. This prolonged Wnt3a stimulation of GSK-3b phosphorylation was PI3K-dependent (data not shown), whereas the stabilization of b-catenin was independent of PI3K ( Figures 3e and 5c ). Furthermore, purified Wnt3a induced b-catenin stabilization was also PI3K independent (Figure 5c ). These results show that ILK modulates Wnt3a-dependent stabilization of b-catenin in a PI3K/ GSK-3 Ser 9 phosphorylation independent manner. Also, in order to determine whether ILK modulates b-catenin stabilization by influencing its phosphorylation, we examined b-catenin phosphorylation by purified Wnt3a in the presence or absence of QLT-0267. As shown in Figure 5d , Wnt3a-dependent phosphorylation of b-catenin was reversed by inhibition of ILK, suggesting that ILK plays a role in Wnt3a-induced stabilization of b-catenin by modulating the upstream signaling cascade that leads to phosphorylation of bcatenin. The precise target(s) of ILK in this cascade have yet to be identified.
ILK interacts with APC and GSK3-b
The finding that ILK activity is required for the acute effects of Wnt3a b-catenin stabilization suggested that ILK might interact with components of the b-catenin destruction complex. Immunoprecipitation of total cell lysate from HEK293 cells with ILK polyclonal antibody showed that ILK can complex with both GSK-3b as well as APC. Stimulation with Wnt3a-CM for 2 h, however, did not affect the formation of these complexes (Figure 6 ), suggesting that this complex is constitutively formed. These results suggest a regulatory role for ILK in the multiprotein b-catenin destruction complex by possibly participating in the conformational changes that occur within this complex as the result of Wnt stimulation.
Discussion
The data presented in this paper demonstrate a novel role for ILK as an important modulator of the canonical Wnt signaling pathway in mammalian cells. ILK has been previously implicated in the activation of some of the downstream components of the Wnt signaling pathway. In particular, ILK has been shown to stabilize b-catenin and increase b-catenin-mediated transcriptional activity (Novak et al., 1998; D'Amico et al., 2000; Persad et al., 2001b; Tan et al., 2001) . b-catenin is also a central player in Wnt-induced gene expression. Regulation of b-catenin by both ILK and Wnt suggests that ILK may intersect with the downstream components of the Wnt pathway. However, to date the role of ILK as an intermediate regulator of Wnt signaling in the activation of b-catenin has not been explored. In this study, we demonstrate, for the first time, the role of ILK as a modulator of the canonical Wnt signaling pathway. We have shown that inhibition of ILK activity results in the abolition of Wnt3a-induced stabilization of b-catenin particularly in the nuclear fraction, and consequently a decrease in Wnt-induced activation of Tcf transcription factor. These results suggest that ILK has a more direct role in the stimulation of Tcf/Lef transcription factors by Wnt proteins, especially Wnt3a. The effect of ILK inhibition on downregulation of b-catenin stabilization was also observed in the MDA231 human breast cancer cells which, together with other breast and ovarian cancer cells, have been previously reported to have a constitutively active Wnt signaling pathway (Bafico et al., 2004) , suggesting that inhibition of ILK may be effective therapeutically for the control of cell growth.
In this report, we also demonstrate an induction of ILK kinase activity in Wnt3a-expressing cells (see Figure 5a ), and this suggests that ILK activity can directly or indirectly be modulated by Wnt3a stimulation. Interestingly, activation of the Wnt pathway has been previously shown to correlate with the induction of ILK kinase activity and elevated cyclin D1 protein levels in the mammary gland of the MMTV-Wnt-1 transgenic mice (D'Amico et al., 2000) . Cellular deficiency of PTEN, a process that constitutively activates ILK, is Equal amounts of lysate (500 mg) were used for immunoprecipitation with ILK polyclonal antibody from HEK293 cells. The immunocomplex was subsequently blotted with antibodies against APC, GSK-3b and ILK. Twenty-five micrograms of the total cell lysates were also blotted with the same antibodies to ensure equal expression of these proteins.
Role of ILK in Wnt3a-mediated b-catenin accumulation A Oloumi et al also known to accelerate mammary oncogenesis in MMTV-Wnt-1 transgenic mice (Li et al., 2001) . In this context, it will be interesting to determine whether ILK enhances Wnt-mediated breast cancer formation in these transgenic mice, and whether inhibiting ILK suppresses this phenotype in the MMTV-Wnt-1 mice. The upregulation of ILK kinase activity may be responsible for the enhanced phosphorylation of GSK3b observed upon stimulation of L cells with W3a-CM or in Wnt3a-expressing L cells as it is also inhibited by treatment with QLT-0267 (see Figure 5b) . The enhancement of GSK-3b phosphorylation on Ser 9 upon treatment with Wnt3a-CM appears, however, to be a secondary effect rather than a direct result of Wnt3a stimulation. L cells treated with purified Wnt3a do not show a significant enhancement in GSK-3 phosphorylation on Ser 9, and treatment with a PI3K inhibitor, LY294002, did not have any effect on purified Wnt3a-mediated b-catenin stabilization. This is consistent with previous reports showing that PI3K does not affect Wnt-mediated b-catenin activity (Kang et al., 2004; Paling et al., 2004; McManus et al., 2005) . These data suggest a PI3K-independent role of ILK in Wnt-induced stabilization and activation of b-catenin. In addition, the reversal of Wnt3a-induced suppression of b-catenin phosphorylation by the ILK inhibitor further suggests that ILK modulates either the Wnt-stimulated activities of upstream kinases (such as CKI or GSK-3) or the interaction of the proteins (such as APC, Axin and GSK-3) involved in the regulation of b-catenin phosphorylation.
We also demonstrate activation of a secondary pathway due in part to the expression of Wnt-responsive genes. The prolonged activation of the Wnt pathway, such as in Wnt3a-expressing cells or cells treated with Wnt3a-CM, could give rise to a cascade of gene expression which may subsequently lead to the activation of growth factor receptors involved in the enhancement in GSK-3 phosphorylation on Ser 9 through ILK in a PI3K-dependent manner.
The data presented here suggest two different roles for ILK in the regulation of the Wnt signaling pathway (Figure 7) . Firstly, as an intermediate regulator in the acute stabilization of b-catenin by Wnt3a, ILK may play a role in the multiprotein b-catenin destruction complex. Our results support this notion as demonstrated by ILK co-immunoprecipitation with APC and GSK-3b. As this association appears to be Wnt-independent, one could speculate that stimulation with Wnt3a induces a conformational change in the APC degradation complex, as has been suggested previously (Li et al., 1999; Salic et al., 2000; Fukumoto et al., 2001) , and that ILK may play an important role in the regulation of this conformational change. Our finding that ILK modulates Wnt3a-induced phosphorylation of b-catenin also supports this hypothesis. ILK has also been shown to associate with Dvl, another component of the Wnt signaling pathway, in a complex with paxillin (Torres and Nelson, 2000) .
Secondly, we have observed that there is a more pronounced effect of ILK inhibition on the nuclear accumulation of b-catenin. Thus, ILK could also play a ILK could also play a role in nuclear localization of b-catenin since the effect of ILK inhibition on the nuclear accumulation of b-catenin seems to be more pronounced. Secondly, expression of Wnt-induced responsive genes could lead to activation of a certain growth factor receptors (GFR), which would then enhance ILK kinase activity in a PI3K dependent manner followed by an enhancement in the phosphorylation of GSK-3b on Ser 9.
Role of ILK in Wnt3a-mediated b-catenin accumulation A Oloumi et al role in nuclear localization of b-catenin. This is consistent with previous data showing that overexpression of ILK in mammary epithelial cells results in nuclear localization of b-catenin without a significant effect on its basal level (Novak et al., 1998; Somasiri et al., 2001) . APC has also been shown to have a nuclear export function, which may be critical for the reduction of b-catenin translocation to the nucleus and hence Tcfdependent transcription of target genes (Rosin-Arbesfeld et al. , 2003) . As our immunoprecipitation results demonstrate an association between ILK and APC, it will be of interest to determine whether ILK plays a role in regulating the nuclear export function of APC.
Although we have shown here that ILK activity is required in mammalian cells for Wnt3a-induced b-catenin/Tcf activation, this function does not appear to be evolutionary conserved. ILK knockdown in Drosophila and Caenorhabditis elegans do not result i n phenotypes resembling the effect of Wnt mutations (Zervas et al., 2001; Mackinnon et al., 2002) , nor does ILK modulate Wnt-induced axis duplication in Xenopus embryos, although the process of gastrulation is profoundly disrupted in ILK-null embryos (Yasunaga et al., 2005) . It remains to be determined whether ILK plays a role in Wnt-induced signaling during mammalian embryonic development, or acquires a role during post-embryonic events, such as wound healing, tissue regeneration and disease processes such as cancer. Interestingly, ILK has recently been shown to play an intermediate role in nerve growth factor induced axon elongation by locally regulating APC and b-catenin accumulation in the growth cone (Zhou et al., 2004) .
Finally, although the precise mechanism of how ILK modulates Wnt3a signaling needs to be determined, the data presented in this paper implicate ILK as an important intermediate regulator of the canonical Wnt signaling pathway in mammalian cells. Both ILK expression as well as Wnt signaling and activity have been implicated in the progression of many types of cancer, suggesting these pathways may act synergistically. In this regard, here we have identified and characterized a novel small molecule inhibitor of ILK, QLT-0267, that can inhibit the canonical Wnt signaling pathway, and could be very useful in the inhibition of the regulatory effects of constitutive Wnt signaling, such as in cancer progression.
Materials and methods
Cell culture HEK293 cells and L cells, an immortalized mouse fibroblast cell line (ATCC, Manassas, VA, USA) were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum. Wnt3a-L cells, the Wnt3a-expressing clone of L cells (ATCC), were maintained in the same medium containing 400 mg/ml G418 as previously described (Shibamoto et al., 1998) .
Activation of Wnt pathway
The Wnt signaling pathway was activated in HEK293 and L cells using CM collected from Wnt3a-expressing L cells (20-50% CM diluted with serum-free DMEM for 30 min to 24 h). Wnt3a-and control C-CM were prepared according to the supplier's instructions (ATCC). In some of the experiments, activation of the canonical Wnt pathway was also achieved by treatment with 100 ng/ml of purified Wnt3a (R&D Systems, Minneapolis, MN, USA).
Treatment with inhibitors HEK293 cells were plated on poly-L-lysine before drug exposure. Both HEK293 and L cells were exposed to QLT-0267 (formerly KP-74728; 10 or 15 mM) (QLT Inc., Vancouver, BC, Canada), a highly selective inhibitors of ILK activity (Persad et al., 2001a; Zhou et al., 2004; Troussard et al., 2006) for 16 h. During overnight CM stimulation, drug treatments were preceded by a 3 h pre-incubation. Cells were also treated with 15 mM of either LY29002 (Sigma, St Louis, MO, USA), or PD98059 (Cell Signaling Technology, Beverely, MA, USA) for 16 h. An equivalent amount of dimethylsulfoxide (DMSO) as a vehicle control was added to all control samples.
Whole cell extract and cell fractionation Whole cell extracts were prepared in NP-40 lysis buffer (1% NP-40 in 50 mM HEPES pH 7.5, 150 mM NaCl) supplemented with the appropriate protease and phosphatase inhibitors (Hannigan et al., 1996) , whereas cytoplasmic and nuclear fractions were prepared as previously described (Troussard et al., 1999) .
Western blots
Equal amounts of lysates were loaded on SDS-polyacrylamide gel electrophoresis (SDS-PAGE) using the Bradford assay (Bio-Rad, Hercules, CA, USA), and Western blots were performed using monoclonal anti-b-catenin, polyclonal antiphospho-GSK-3 a/b Ser 9/21, monoclonal anti-GSK-3, monoclonal anti-ILK (all from New England Biolabs, Beverely, MA, USA), polyclonal anti-ILK (Upstate, Lake Placid, NY, USA), polyclonal anti P-Ser 33/37/Thr41 bcatenin (cell signaling), anti-Histone (Chemicon, Temecula, CA, USA), anti-b-actin (Sigma) and antibodies.
Immunoprecipitation Whole-cell lysates (500 mg) were pre-cleared with protein A Sepharose beads (Sigma) for 1 h at 41C, followed by overnight incubation with 3 mg of polyclonal ILK antibody while rotating overnight at 41C. Protein A Sepharose was added to the lysates for 1 h before washing the immunocomplex three times with cold lysis buffer. The samples were then subjected to Western blotting with the indicated antibodies.
Immunofluorescence microscopy L cells grown on poly-L-Lysine-coated glass coverslips were treated with the ILK inhibitors or an equivalent amount of DMSO before and during stimulation with CM. Cells were then fixed for 20 min in 4% paraformaldehyde followed by permeablization with phosphate buffer saline (PBS) containing 0.2% Triton X-100 for 1.5 h. Cells were blocked in 10% normal goat serum and 1% bovine serum albumin in PBS for 30 min, followed by incubation with monoclonal anti-bcatenin (1:100) (New England Bioloabs) or immunoglobulin G in humidified chamber at 41C overnight. Protein was detected with anti-mouse fluorescein isothiocyanate-conjugated secondary antibody (Santa Cruz Biotechnology). Slides were counter-stained in DAPI, mounted and viewed using a Zeiss Fluorescent Microscope with an attached Sensicam Camera. The images were digitized using Northern Eclipse 5.0 software (Empix, Toronto, ON, Canada).
Luciferase reporter assay HEK293 cells plated on poly-L-lysine-coated plates were transfected with pcDNA3.1, pcDNA3.1 ILK-WT:V5 or pcDNA3.1 ILK-DN:V5 to a total of 2 mg DNA and 0.5 mg of either TOP-or FOP-Flash reporter constructs, and 2.5 ng pRenilla as reporter control using Lipofectamine 2000 (Invitrogen, Burlington, ON, Canada) according to the manufacturer's instructions. At 24 h post-transfection the cells were stimulated with either Wnt3a-or C-CM overnight. The luciferase assay was performed using the dual luciferase assay reporter kit according to the manufacturer's instructions (Promega, Madison, WI, USA). For treatment with ILK inhibitor, cells were transfected for 24 h with the reporter constructs followed by an overnight treatment with QLT-0267.
ILK kinase assay Serum-starved parental and Wnt3a-expressing L cells were lysed in NP-40 lysis buffer for 30 min. Two hundred and fifty micrograms of protein was then immunoprecipitated with 5 mg of either polyclonal anti-ILK or the control polyclonal anti-HA antibodies (both from upstate) as described above. The immunocomplexes were washed twice with the above NP-40 lysis buffer containing 750 mM NaCl, and then twice with wash buffer containing 50 mM HEPES pH 7.5, 85 mM KCl, 10 mM ethyleneglycol tetraacetate (EGTA), 0.1% Tween 80, 1 mM Na 3 VO 4 , 10 mM Mg 2 Cl (Erdodi et al., 2003) . The kinase assay was performed in 25 ml of reaction buffer containing, 5 mCi [g-32 P]ATP, and 5 mg of synthetic peptides PHI-A (KRHAR VAVKYDRREL) as a control or PHI-Thr (KRHARVTV KYDRREL) (Sigma), as the substrate based on the phosphorylation of PHI-1 on Thr 57 by ILK (Erdodi et al., 2003) . Substrate phosphorylation was detected by spotting the reactions on P81 paper discs, and quantification in a scintillation counter.
Statistical analysis
Data presented in the graphs represent the mean7s.e. of results. The minimum level of statistical significance was set at a ¼ 0.05. Inter-group comparison was made with a paired twosample t-test.
Densitometric analysis
The intensities of bands in relevant blots were analyzed using the Quantity One program from BioRad (Cambridge, MA, USA). Values are shown as the fraction of the control sample.
